Summary
Immunotherapies using tumor-fighting T cells, like TILs , or T cells engineered with specialized receptors (CAR or TCR), have been game-changers in cancer treatment. They have shown remarkable success in treating blood cancers like leukemia and lymphoma, but their efficacy...